Kymera Therapeutics Inc.
KYMR | NASDAQ
$117.67
-$0.08 (-0.07%)
At close: Sep 21, 2026, 4:00 PM ET
$117.51
-$0.16 (-0.14%)
Pre-market:
Sep 22, 2026, 9:03 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 104.99M | 51.47M | 39.2M | 43.73M | 44.71M | 58.89M | 47.07M | 87.56M | 88.55M | 79.41M | 78.59M | 46.85M | 51.67M | 46.67M | 46.83M | 45.96M | 56.75M | 63.75M | 72.83M | 70.34M | 64.54M | 49.31M |
Cost of Revenue | -2.08M | n/a | n/a | 76.18M | 2.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 107.07M | 51.47M | 39.2M | -32.44M | 42.63M | 58.89M | 47.07M | 87.56M | 88.55M | 79.41M | 78.59M | 46.85M | 51.67M | 46.67M | 46.83M | 45.96M | 56.75M | 63.75M | 72.83M | 70.34M | 64.54M | 49.31M |
Operating Income | -350.18M | -359.13M | -349.4M | -332.26M | -311.86M | -278.23M | -261.64M | -200.19M | -185.58M | -178.04M | -165.53M | -184.85M | -172.22M | -169.65M | -161.26M | -156.62M | -140.37M | -124.29M | -100.53M | -79.32M | -58.76M | -48.23M |
Interest Income | 50.52M | 44.09M | 38.03M | 37.38M | 36.73M | 37.6M | 38.03M | 32.96M | 27.95M | 23.65M | 18.76M | 17.59M | 14.83M | 10.79M | 6.62M | 2.94M | 1.15M | 657K | 485K | 465K | 465K | 595K |
Pretax Income | -299.87M | -315.28M | -311.62M | -295.12M | -275.43M | -240.88M | -223.86M | -167.47M | -157.85M | -154.59M | -146.96M | -167.46M | -157.59M | -159.05M | -154.81M | -153.84M | -139.42M | -123.83M | -100.22M | -79M | -58.41M | -47.74M |
Net Income | -299.65M | -315.05M | -311.4M | -295.12M | -275.43M | -240.88M | -223.86M | -167.47M | -157.85M | -154.59M | -146.96M | -167.46M | -157.59M | -159.05M | -154.81M | -153.84M | -139.42M | -123.83M | -100.22M | -79M | -58.41M | -47.74M |
Selling & General & Admin | 75.77M | 72.29M | 68.2M | 67.58M | 65.7M | 65.43M | 63.53M | 61.43M | 60.09M | 56.85M | 55.04M | 52.45M | 48.89M | 45.79M | 43.83M | 43.94M | 44.05M | 41.05M | 36.35M | 29.78M | 25.95M | 21.58M |
Research & Development | 375.6M | 334.51M | 316.6M | 304.55M | 290.87M | 271.68M | 240.25M | 221.4M | 209.11M | 195.67M | 189.08M | 179.24M | 175M | 170.53M | 164.25M | 158.64M | 153.07M | 147M | 137.02M | 119.88M | 97.35M | 75.95M |
Other Expenses | 5.88M | 3.8M | 3.8M | -72.32M | -2.08M | n/a | 4.93M | 4.93M | 4.93M | 4.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 457.25M | 410.59M | 388.6M | 299.82M | 354.49M | 337.12M | 308.71M | 287.76M | 274.13M | 257.45M | 244.12M | 231.69M | 223.89M | 216.32M | 208.08M | 202.58M | 197.12M | 188.05M | 173.36M | 149.66M | 123.3M | 97.53M |
Interest Expense | 211K | 238K | 249K | 239K | 299K | 252K | 249K | 242K | 223K | 210K | 196K | 202K | 197K | 190K | 176K | 168K | 202K | 189K | 172K | 149K | 107K | 104K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 455.17M | 410.59M | 388.6M | 375.99M | 356.57M | 337.12M | 308.71M | 287.76M | 274.13M | 257.45M | 244.12M | 231.69M | 223.89M | 216.32M | 208.08M | 202.58M | 197.12M | 188.05M | 173.36M | 149.66M | 123.3M | 97.53M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 98.18M | 97.53M | 84.39M | 87.3M | 80.45M | 80.15M | 79.99M | 76.13M | 73.06M | 70.77M | 58.52M | 58.42M | 58.33M | 58.19M | 57.89M | 54.54M | 51.77M | 51.65M | 51.39M | 50.71M | 45.09M | 44.65M |
Shares Outstanding (Diluted) | 98.18M | 97.53M | 84.39M | 87.3M | 80.45M | 80.15M | 79.99M | 76.13M | 73.06M | 70.77M | 58.52M | 58.42M | 58.33M | 58.19M | 57.89M | 54.54M | 51.77M | 51.65M | 51.39M | 50.71M | 45.09M | 44.65M |
EPS (Basic) | -3.25 | -3.58 | -3.69 | -3.59 | -3.47 | -3.10 | -2.97 | -2.34 | -2.42 | -2.51 | -2.45 | -2.79 | -2.68 | -2.78 | -2.86 | -2.93 | -2.70 | -2.48 | -2.06 | -1.69 | -1.31 | -1.08 |
EPS (Diluted) | -3.25 | -3.58 | -3.69 | -3.59 | -3.47 | -3.10 | -2.97 | -2.34 | -2.42 | -2.51 | -2.45 | -2.79 | -2.68 | -2.78 | -2.86 | -2.93 | -2.70 | -2.48 | -2.06 | -1.69 | -1.31 | -1.08 |
EBITDA | -292.76M | -306.05M | -302.36M | -285.92M | -267.03M | -232.67M | -216.24M | -160.98M | -152.47M | -150.26M | -143.2M | -163.74M | -154.01M | -155.67M | -151.66M | -150.83M | -136.47M | -121.04M | -97.65M | -76.65M | -56.28M | -45.77M |
EBIT | -299.66M | -315.04M | -311.37M | -294.88M | -275.14M | -240.63M | -223.61M | -167.23M | -157.63M | -154.38M | -146.77M | -167.26M | -157.4M | -158.86M | -154.63M | -153.67M | -139.22M | -123.64M | -100.04M | -78.85M | -58.3M | -47.63M |
Depreciation & Amortization | 6.9M | 8.99M | 9.01M | 8.97M | 8.11M | 7.96M | 7.37M | 6.25M | 5.16M | 4.13M | 3.57M | 3.52M | 3.39M | 3.19M | 2.98M | 2.85M | 2.75M | 2.6M | 2.4M | 2.21M | 2.02M | 1.86M |
Add to Watchlist
Select watchlists to add or remove KYMR